Bluebird bio Inc (NASDAQ: BLUE) open the trading on Wednesday, with a bit cautious approach as it glided -5.56% to $1.19, before settling in for the price of $1.26 at the close. Taking a more long-term approach, BLUE posted a 52-week range of $0.88-$5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its Annual Earning per share during the time was 15.14%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.88%. This publicly-traded company’s shares outstanding now amounts to $192.74 million, simultaneously with a float of $189.83 million. The organization now has a market capitalization sitting at $229.36 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2546, while the 200-day Moving Average is $2.5882.
Bluebird bio Inc (BLUE) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Bluebird bio Inc’s current insider ownership accounts for 1.51%, in contrast to 67.31% institutional ownership. According to the most recent insider trade that took place on Mar 04 ’24, this organization’s President and CEO sold 6,095 shares at the rate of 1.53, making the entire transaction reach 9,311 in total value, affecting insider ownership by 279,998. Preceding that transaction, on Mar 04 ’24, Company’s insider sold 4,573 for 1.53, making the whole transaction’s value amount to 6,986. This particular insider is now the holder of 124,840 in total.
Bluebird bio Inc (BLUE) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 9/29/2023 suggests? It has posted -$0.66 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.67) by $0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
Bluebird bio Inc’s EPS increase for this current 12-month fiscal period is 10.88% and is forecasted to reach -0.88 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.80% through the next 5 years, which can be compared against the 15.14% growth it accomplished over the previous five years trading on the market.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Let’s observe the current performance indicators for Bluebird bio Inc (BLUE). It’s Quick Ratio in the last reported quarter now stands at 1.42. The Stock has managed to achieve an average true range (ATR) of 0.13. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.56.
In the same vein, BLUE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.74, a figure that is expected to reach -0.44 in the next quarter, and analysts are predicting that it will be -0.88 at the market close of one year from today.
Technical Analysis of Bluebird bio Inc (BLUE)
[Bluebird bio Inc, BLUE] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.09% While, its Average True Range was 0.1191.
Raw Stochastic average of Bluebird bio Inc (BLUE) in the period of the previous 100 days is set at 6.69%, which indicates a major fall in contrast to 28.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 101.80% that was lower than 166.96% volatility it exhibited in the past 100-days period.
